Opus Genetics (IRD) Return on Capital Employed Growth (3y) (2021 - 2026)
Opus Genetics (IRD) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -3,782.00 |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | -13,073.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,073.00 |
| Dec 31, 2025 | -17,182.00 |
| Sep 30, 2025 | -62,119.00 |
| Jun 30, 2025 | -14,195.00 |
| Mar 31, 2025 | -23,231.00 |
| Dec 31, 2024 | -11,789.00 |
| Sep 30, 2024 | 6,093.00 |
| Jun 30, 2024 | 14,279.00 |
| Mar 31, 2024 | 15,224.00 |
| Dec 31, 2023 | 17,712.00 |
| Sep 30, 2023 | 7,898.00 |
| Jun 30, 2023 | 6,289.00 |
| Mar 31, 2023 | 10,702.00 |
| Dec 31, 2022 | -37,325.00 |
| Sep 30, 2022 | -5,710.00 |
| Jun 30, 2022 | -2,688.00 |
| Mar 31, 2022 | 238.00 |
| Dec 31, 2021 | 6,472.00 |